共 50 条
- [45] Expert Perspective: Reducing Cardiovascular Risk in Metabolic Syndrome and Type 2 Diabetes Mellitus Beyond Low-Density Lipoprotein Cholesterol Lowering AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 41L - 47L
- [46] Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus Advances in Therapy, 2015, 32 : 1085 - 1103
- [47] Plasma Low-Density Lipoprotein Cholesterol Correlates With Heart Function in Individuals With Type 2 Diabetes Mellitus: A Cross-Sectional Study FRONTIERS IN ENDOCRINOLOGY, 2019, 10
- [48] Influence of Dapagliflozin Dosing on Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta-Analysis JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (12): : 1528 - 1540
- [49] Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus Cardiovascular Diabetology, 22